Non-Hodgkin-Lymphom (NHL)Maria Yiallouros
Non-Hodgkin-Lymphom (NHL) Author links open overlay panelChristoff ZalpourShow more Add to Mendeley Share Cite https://doi.org/10.1016/B978-3-437-45023-5.00129-2Get rights and contentAccess through your organization Check access to the full text by signing in through your organization. Access...
Secondary efficacy subanalysis by histology from the phase III BRIGHT study: First-line bendamustine-rituximab (BR) compared with standard R-CHOP/R-CVP for patients with advanced indolent non-Hodgkin lymphoma (NHL) or mantle cell lymphom... 8537 Background: BR was previously reported to be stati...
Efficacy and safety of the combination of rituximab, fludarabine, and mitoxantrone for rituximab-naive, recurrent/refractory follicular non-Hodgkin lymphom... BACKGROUND:This phase 2 trial was undertaken to evaluate the efficacy and safety of rituximab combined with intravenous fludarabine and mitoxantrone...
12.18 Non-Hodgkin-Lymphom (NHL)doi:10.1055/b-002-101350
31.3 Non-Hodgkin-Lymphom (NHL)doi:10.1055/b-002-21544
Hodgkin Lymphom , High Grade NHL Hodgkin-LymphomSchmitt
Non Hodgkin lymphoma (NHL) is the most frequent cancer in patients with HIV/AIDS (PWHA) in the post-cART era. Interestingly, an increase in Hodgkin lymphom... Carbone,Antonino - 《Jaids Journal of Acquired Immune Deficiency Syndromes》 被引量: 4发表: 2014年 ...
被引量: 0发表: 0年 Hodgkin and Non-Hodgkin lymphoma The incidence of malignant lymphomas stands at about five new cases per 100 000 persons per year. These include instances both of Hodgkin's disease (HD) an... F Moog - Steinkopff 被引量: 2发表: 2000年 加载更多站...